FT : Boards of Fiat Chrysler and Peugeot-owner PSA to meet over merger

Boards of Fiat Chrysler and Peugeot-owner PSA to meet over merger
Both groups’ shares jump as they prepare to sign off on plans to pursue full-scale tie-up

The boards of France’s PSA, owner of Peugeot, and Fiat Chrysler Automobiles are set to meet this week to sign off on plans to pursue a full-scale merger between the two European carmakers.

The two sides are expected to release a memorandum of understanding outlining the terms of a discussion that may create a combined group with a market value in excess of €44bn, according to people close to the discussions.

The companies are discussing basing the combined group in the Netherlands, a neutral location, where FCA is already domiciled.

Multiple people familiar with the deal said that a possible iteration would be an all-stock merger in which PSA chief executive Carlos Tavares runs the business and John Elkann — the scion of Italy’s Agnelli family, which controls FCA — becomes chairman.

“John Elkann has been trying to do a deal forever,” said one person close to the talks. Another said discussions between Mr Tavares and Mr Elkann had been on and off throughout this year. They broke off during FCA’s attempted merger with Renault before beginning again more recently.

Shares in FCA have vastly underperformed PSA’s since the start of the year, strengthening the French company’s negotiating position and giving it additional leverage in discussions with Mr Elkann’s family vehicle Exor, the dominant shareholder in FCA.

The two companies are expected to stress the industrial logic of the deal, given the complementary geography of the French and Italian-American businesses.

A combined group would cut administrative and manufacturing costs. There are also hopes that greater savings could be achieved when purchasing supplies and not having to duplicate capital spending to fund upgrades to company capabilities in a transforming car industry.

However, the people cautioned that auto mergers were among the most difficult deals to pursue, given the emotional attachment to the businesses, the egos of car industry executives and the challenges in aligning various influential shareholders.

The French state, which owns 12 per cent of PSA and which has been blamed for the collapse of the merger attempt with Renault, said on Wednesday morning that it would be “particularly vigilant on the preservation of the industrial footprint” and “the governance of the new entity”.

One person close to the deal suggested it was less likely that the French state would prove a barrier to a deal between PSA and FCA, in part due to the lessons learnt from the Renault attempt and in part because they believe that carmakers need scale to survive in an increasingly challenging environment.

Analysts at UBS have “estimated that a merger could yield annual synergies of €3bn to €6.6bn, equivalent to about 25 to 55 per cent of combined estimated 2020 earnings”.

“It’s obvious that PSA does not offer any synergies in the US, and very little in LatAm. Putting PSA and FCA together in China doesn’t solve much either: two wrongs don’t make a right. A deal does nothing to change Alfa and Maserati’s prospects,” cautioned Max Warburton at Bernstein.

“The focus will be Europe — where subscale product lines, powertrains and future electric vehicle investments could be combined,” he added.

Shares in the two carmakers jumped on Wednesday after they confirmed talks that were first revealed on Tuesday evening.

PSA’s shares rose 6 per cent to €26.46 by mid-morning, giving it a market value of €24bn. FCA’s shares were up by 9 per cent to €12.89, raising its market value to €20bn.

>>> US Gapping down

Gapping down
In reaction to disappointing earnings/guidance
:

  • QUAD -19.3%, ENPH -10.3%, CSII -9%, AJRD -8.7%, TUP -8.3%, LDL -7%, MOH -7%, ACCO -6.5%, CHRW -6.1%, DB -5.9%, CRTO -5.9%, EXAS -5.6%, NBR -5%, EXTR -4.9%, DAN -4.8%, YUM -4.7%, SAN -4.4%, CYH -4.1%, CCS -4%, SAIA -3.8%, FEYE -3.7%, RNR -3.6%, APTV -3.5%, SYK -3.3%, NYCB -3.2%, CS -2.4%, AX -2.3%, UNM -2.3%, BG -2.1%, MDLZ -1.6%, GNW -1.6%, VNOM -1.6%, TMHC -1.6%, MAS -1.5%, EIX -1.4% (also says filed Electric Safety Incident Repor related to the Saddle Ridge fire out of abundance of caution because SCE had an event on its system close in time to the start of the fire), LSCC -1.4%, IQV -1.4%, MSTR -1.2%, OKE -1.1%, CIM -1.1%

Other news:

  • AMAG -22.7% (FDA AdCom in final voting question votes in favor of pursuing withdrawal of approval for Makena)
  • CPRX -14% (announces top-line results from CMS-001)
  • YMAB -9.3% (commences registered underwritten public offering of up to $125 million in shares of its common stock)
  • SESN -7% (under pressure after modifying 2017 and 2018 common stock warrants to allow for future at-the-market programs)
  • MOH -7% (discloses that Texas Health and Human Services Commission notifies that it intends to award contracts to Molina Healthcare of Texas, Inc. for the STAR+PLUS program in the Hidalgo and North East service areas)
  • FBC -3.9% (commences public secondary offering of 6.1 mln shares of common stock by MP Thrift Investments L.P.)
  • NWBI -2.4% (Northwest Bancshares to acquire MutualFirst Financial in all-stock transaction valued at approx. $346 mln)
  • SEDG -1.5% (following ENPH results)
  • NVS -1.5% (announces AVXS-101 intrathecal study update; FDA placed a partial hold on AVXS-101)

Analyst comments:

  • GRUB -4.2% (downgraded to Neutral from Buy at Goldman, among others)
  • AMCX -1.9% (downgraded to Neutral from Buy at BofA/Merrill)
  • LEG -1.3% (downgraded to Hold from Buy at SunTrust)
  • CR -1% (downgraded to Hold from Buy at Canaccord Genuity)
  • MAN -0.9% (downgraded to Hold from Buy at Argus)

>>> US Gapping up

Gapping up
In reaction to strong earnings/guidance
:

  • MAT +20.8%, OSPN +19.8%, AXE +13.9%, TENB +13.4%, SIMO +12.8%, UIS +11.9%, IPHI +10.2%, MGRC +7.1%, MXIM +6.7%, GE +6.3%, GRMN +6%, CROX +5%, WING +5%, SILK +4.5%, ZEN +4.4%, CXO +4.4%, AR +3.9%, UTHR +3.5%, WCG +3.3%, HLF +3% (also announces John Agwunobi as new CEO, effective March 2020), KBR +2.8%, AM +2.7%, RRD +2.7%, WYND +2.4%, EPR +2.2%, MTDR +2.2%, CME +2%, ACGL +1.9%, ARQL +1.8%, NATI +1.5% (also announces Eric Starkloff as new CEO after Alex Davern steps down), LHX +1.5%, MDU +1.4%, SGEN +1.4%, FMC +1.3%, ALL +1.3%, ETR +1.2%, ADP +1.2%, AMED +1.1%, HPP +1.1%, SUM +1.1%, DENN +1%, PSMT +1%, CB +0.9%, SNE +0.8%

M&A news:

  • AXE +13.9% (to be acquired by Clayton, Dubilier & Rice for $81/share in cash, or approximately $3.8 bln; also reported earnings)
  • VNE +3.9% (divests Chinese and Japanese JVs)

Other news:

  • GDOT +23.6% (Green Dot and Walmart extend relationship through two agreements)
  • PCG +15.7% (ongoing volatility; was up 32% on the day)
  • CYCN +5% (announces top-line results from CAPACITY Phase 2 study of praliciguat and from study of praliciguat in diabetic nephropathy; the studies did not meet statistical significance on primary endpoints)
  • CARB +3.2% (after late spike higher on M&A speculation)
  • JNJ +2.7% (announces that 15 new tests from the same bottle of Johnson's Baby Powder previously tested by the FDA found no asbestos)
  • FIT +1.7% (continued strength)
  • AZN +1.4% (divests rights to Seroquel and Seroquel XR in Europe and Russia)

Analyst comments:

  • BIIB +2.5% (upgraded to Outperform from Mkt Perform at Bernstein)
  • MCHP +2% (upgraded to Strong Buy from Mkt Perform at Raymond James)
  • NUS +1.1% (upgraded to Hold from Sell at Stifel)

>>> US Early premarket gappers

Early premarket gappers

  • Gapping up:
    • OSPN +22.9%, MAT +18.3%, GDOT +16.5%, SIMO +15.1%, UIS +13.4%, IPHI +10.2%, PCG +8.3%, TENB +7.2%, MXIM +6.7%, CXO +5.8%, MGRC +5.6%, SILK +4.5%, ZEN +3.9%, AR +3.9%, FMC +3.6%, UTHR +3.5%, PSMT +3.1%, HLF +3%, JNJ +2.8%, RRD +2.7%, CB +2.3%, EPR +2.2%, MTDR +2.2%, BIIB +2.1%, KBR +2.1%, ACGL +1.9%, SAM +1.7%, NATI +1.5%, MDU +1.4%, MAS +1.2%, AM +1.2%, AMED +1.1%, SUM +1.1%, DENN +1%, CARB +0.9%, SNE +0.9%,
  • Gapping down:
    • QUAD -26.7%, ENPH -10.3%, CSII -9%, AJRD -8.7%, EXAS -8.4%, CHRW -8.2%, SESN -7%, LDL -7%, ACCO -6.5%, DB -5.3%, NBR -5%, CYH -4.1%, CCS -4%, FEYE -3.7%, RNR -3.6%, YUMC -3.3%, SYK -3%, SAN -3%, FBC -2.8%, NWBI -2.4%, AX -2.3%, UNM -2.3%, MRCY -2.2%, BG -2.1%, AMD -2%, BXP -1.9%, CS -1.8%, EIX -1.7%, MDLZ -1.6%, GNW -1.6%, VNOM -1.6%, SEDG -1.5%, EA -1.5%, LSCC -1.4%, MSTR -1.2%, OKE -1.1%

FT : Deutsche Bank hit by drop in fixed income trading revenues

Deutsche Bank hit by drop in fixed income trading revenues
Germany’s biggest lender in bid to turn round investment bank

Deutsche Bank’s fixed income trading unit trailed well behind rivals during the third quarter in the latest sign of the steep hurdles Germany’s biggest lender faces in its bid to turn round the fortunes of its investment bank.

Revenue in fixed income trading — by far the biggest remaining unit of Deutsche’s downsized investment bank — fell 13 per cent year-on-year to €1.23bn. The decline is further evidence that Deutsche is falling behind its large US rivals which on average reported an 11 per cent increase in the metric.

Deutsche blamed the decline in fixed income trading, which includes bonds and currencies, on low market volatility in foreign exchange markets. It also pointed to “business restructuring and challenging market conditions” in its rates unit, which handles sovereign bonds and other related products, and emerging markets debt which triggered “some risk management losses”.

The investment bank’s pre-tax profit tumbled 73 per cent to €64m. Due to a change in its financial reporting structure and the restructuring, a detailed analyst consensus did not exist prior to the quarterly results.

On the group level, a 15 per cent fall in revenue and restructuring costs led to a net loss of €832m in the quarter. While the core bank generated €352m in pre-tax profit, Deutsche’s bad bank, which is home to the group’s unwanted assets, sustained a €1bn loss before tax. The lender said its asset disposals were on track. It also reconfirmed its cost-cutting target for the full year.

For the first time since the acquisition of German retail bank Postbank a decade ago, the number of employees has fallen slightly below the symbolic threshold of 90,000.

Its core tier one equity ratio — a key indicator of balance sheet strength — was unchanged compared to the previous quarter at 13.4 per cent.

Chief executive Christian Sewing stressed in a statement that all four core business units were profitable “despite having launched the most comprehensive restructuring of our bank in two decades”.

>>> Stoxx 600 Pre-Market Indications

  • Fiat Chrysler (2FI TH) +9.6%
    • Fiat Chrysler, PSA Confirm They’re Exploring Potential Tie-Up
  • Fuchs Petrolub (FPE3 TH) +4.7%
    • Fuchs Petrolub 9M Rev. Flat; Sees FY Sales, Ebit at Top of Views
  • Banco Santander (BSD2 TH) +4%
    • Santander Offsets Lackluster Europe With Latin America Gains
  • MorphoSys (MOR TH) +3%
  • VW (VOW3 TH) +1.1%
    • Volkswagen Lowers Sales Outlook as Demand Decline Accelerates
  • L’Oreal (LOR TH) +1%
    • L’Oreal 3Q ‘Awesome’ With No Sign of Slowdown in China: RBC
  • Fresenius SE (FRE TH) +0.9%
  • Lufthansa (LHA TH) +0.8%
    • Lufthansa, Norwegian Raised as Capacity Issues Recede: Bernstein
  • SocGen (SGE TH) +0.7
  • Air Liquide (AIL TH) +0.5%
  • Siemens Healthineers (SHL TH) -0.8%
  • Commerzbank (CBK TH) -0.8%
  • Evotec SE (EVT TH) -0.8%
  • Mowi (PND TH) -1.1%
    • Mowi Third Quarter Ebit Misses Estimates
  • TAG Immobilien (TEG TH) -1.5%
    • TAG Immobilien Keeps 2019 Views, Sees 2020 FFO EU168m-170m
  • Deutsche Bank (DBK TH) -1.6%
    • Deutsche Bank Revenue Falls Again on Fixed Income Trading Slump
  • Renault (RNL TH) -1.8
  • Lanxess (LXS TH) -1.8%
    • Lanxess Cut to Hold at Bankhaus Metzler
  • Airbus (AIR TH) -2.1%
    • Airbus Struggles to Cash In on Boeing’s 737 Max Crisis
  • Eurofins Scientific (ESF TH) -2.6%